- Home
- FLYE vs BMRA Comparison
FLYE vs BMRA Comparison
Compare FLYE & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLYE
- BMRA
- Stock Information
- Founded
- FLYE 2018
- BMRA 1971
- Country
- FLYE United States
- BMRA United States
- Employees
- FLYE N/A
- BMRA N/A
- Industry
- FLYE Aerospace
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- FLYE Industrials
- BMRA Health Care
- Exchange
- FLYE Nasdaq
- BMRA Nasdaq
- Market Cap
- FLYE 10.2M
- BMRA 9.2M
- IPO Year
- FLYE 2024
- BMRA N/A
- Fundamental
- Price
- FLYE $0.52
- BMRA $3.67
- Analyst Decision
- FLYE
- BMRA
- Analyst Count
- FLYE 0
- BMRA 0
- Target Price
- FLYE N/A
- BMRA N/A
- AVG Volume (30 Days)
- FLYE 117.4K
- BMRA 48.3K
- Earning Date
- FLYE 05-23-2025
- BMRA 04-14-2025
- Dividend Yield
- FLYE N/A
- BMRA N/A
- EPS Growth
- FLYE N/A
- BMRA N/A
- EPS
- FLYE N/A
- BMRA N/A
- Revenue
- FLYE $28,547,111.00
- BMRA $5,678,000.00
- Revenue This Year
- FLYE N/A
- BMRA N/A
- Revenue Next Year
- FLYE N/A
- BMRA N/A
- P/E Ratio
- FLYE N/A
- BMRA N/A
- Revenue Growth
- FLYE N/A
- BMRA 5.01
- 52 Week Low
- FLYE $0.33
- BMRA $1.92
- 52 Week High
- FLYE $7.62
- BMRA $10.16
- Technical
- Relative Strength Index (RSI)
- FLYE N/A
- BMRA 46.61
- Support Level
- FLYE N/A
- BMRA $3.41
- Resistance Level
- FLYE N/A
- BMRA $3.74
- Average True Range (ATR)
- FLYE 0.00
- BMRA 0.30
- MACD
- FLYE 0.00
- BMRA 0.05
- Stochastic Oscillator
- FLYE 0.00
- BMRA 43.29
About FLYE Fly-E Group Inc. Common Stock
Fly-E Group Inc is an electric vehicle company that is principally engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters and related accessories under the brand Fly E-Bike. It also provides connectivity solutions and value-added services to their customers.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.